EUVIMEDEUVIMED entdecken
Open Access

Assessment of Mobility Trajectories Using Wearable Inertial Sensors During Autologous Hematopoietic Cell Transplant

Meghan B Skiba, Mahmoud El-Gohary, Fay Horak, Nathan F Dieckmann, Carolyn Guidarelli, Gabrielle Meyers, Brandon Hayes-Lattin, Kerri Winters-Stone

Archives of Physical Medicine and Rehabilitation · 2024

DOI: 10.1016/j.apmr.2024.01.019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Physical Medicine and Rehabilitation, 2024. Verfasst von Meghan B Skiba und 7 weiteren Autor:innen. Beteiligte Einrichtung: Advanced Nursing Practice and Science Division, College of Nursing, University of Arizona, Tucson, AZ; University of Arizona Cancer Center, Tucson, A…. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Wearable Electronic Devices, Hematologic Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: This study aimed to characterize mobility patterns using wearable inertial sensors and serial assessment across autologous hematopoietic cell transplant (autoHCT) and investigate the relation between mobility and perceived function in patients with hematologic cancer. DESIGN: Prospective longitudinal study. SETTING: Hospital adult transplant clinic followed by discharge. PARTICIPANTS: 78 patients with hematological cancer receiving autoHCT. MAIN OUTCOME MEASURES: Mobility was measured across 3 clinical phases (pretransplant, pre-engraftment, and post-engraftment) in using inertial sensors worn during prescribed performance tests in the hospital. Perceived function was assessed using validated provider-reported (Eastern Cooperative Oncology Group [ECOG] Performance Status Scale) and patient-reported [European Organization for Research and Treatment of Cancer Quality of Life Questionnaire [EORTC QLQ-C30]) measures. Trajectories of 5 selected mobility characteristics (turn duration, gait speed, stride time variability, double support time, and heel strike angle) across the clinical phases were also evaluated using piecewise linear mixed-effects models. RESULTS: Using Principal Components Analysis, 4 mobility patterns were identified pretransplant: Gait Limitation, Sagittal Sway, Coronal Sway, and Balance Control. Gait Limitation measured pretransplant was significantly inversely associated with perceived function reported by the provider- (β = -0.11; 95% CI: -0.19, -0.02) and patient- (β = -4.85; 95% CI: -7.72, -1.99) post-engraftment in age-adjusted linear regression models. Mobility characteristics demonstrated immediate declines early pre-engraftment with stabilization by late pre-engraftment. CONCLUSION: Patients with hematological cancer experiencing gait limitations pretransplant are likely to have worse perceived function post-engraftment. Mobility declines in early phases post-transplant and may not fully recover, indicating an opportunity for timely rehabilitation referrals. Wearable inertial sensors can be used to identify early mobility problems and patients who may be at risk for future functional decline who may be candidates for early physical rehabilitation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationWearable Electronic DevicesHematologic NeoplasmsHumansMaleFemaleMiddle AgedProspective StudiesLongitudinal StudiesAdultTransplantation, AutologousPostural BalanceAgedMobility LimitationQuality of LifeWalking Speed

Stichwörter der Autor:innen

DisabilityGait analysisHematologic neoplasmsMultiple myelomaPhysical functional performancePostural balanceRehabilitation

Autor:innen und Institutionen

  • Advanced Nursing Practice and Science Division, College of Nursing, University of Arizona, Tucson, AZ; University of Arizona Cancer Center, Tucson, AZ; Division of Oncological Sciences, Knight Cancer Institute, School o…
  • APDM, a Clario Inc Company, Portland, OR.
  • APDM, a Clario Inc Company, Portland, OR; Department of Neurology, School of Medicine, Oregon Health & Science University, Portland OR.
  • School of Nursing, Oregon Health & Science University, Portland, OR.
  • Division of Oncological Sciences, Knight Cancer Institute, School of Medicine, Oregon Health & Science University, Portland OR.
  • Division of Hematology and Medical Oncology, School of Medicine, Oregon Health & Science University, Portland, OR.

Förderung

  • NCI NIH HHS
  • National Institutes of Health

Zitieren

APA

Skiba, M. B., El-Gohary, M., Horak, F., Dieckmann, N. F., Guidarelli, C., Meyers, G., Hayes-Lattin, B., & Winters-Stone, K. (2024). Assessment of Mobility Trajectories Using Wearable Inertial Sensors During Autologous Hematopoietic Cell Transplant. Archives of Physical Medicine and Rehabilitation. https://doi.org/10.1016/j.apmr.2024.01.019

Vancouver

Skiba MB, El-Gohary M, Horak F, Dieckmann NF, Guidarelli C, Meyers G, et al. Assessment of Mobility Trajectories Using Wearable Inertial Sensors During Autologous Hematopoietic Cell Transplant. Archives of Physical Medicine and Rehabilitation. 2024. doi:10.1016/j.apmr.2024.01.019

BibTeX
@article{Skiba2024,
  author = {Skiba, Meghan B and El-Gohary, Mahmoud and Horak, Fay and Dieckmann, Nathan F and Guidarelli, Carolyn and Meyers, Gabrielle and Hayes-Lattin, Brandon and Winters-Stone, Kerri},
  title = {Assessment of Mobility Trajectories Using Wearable Inertial Sensors During Autologous Hematopoietic Cell Transplant},
  journal = {Archives of Physical Medicine and Rehabilitation},
  year = {2024},
  doi = {10.1016/j.apmr.2024.01.019}
}
Kostenlos starten →